JPRN-jRCT1011230058尚未招募Unknown
Comparison of efficacy and safety of tamsulosinand vibegron for male lower urinary tract symptoms-Multicenter randomized crossover study- - ALPHABET study
Wada Naoki0 个研究点目标入组 60 人开始时间: 2024年1月26日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 ot applicable（—）
- 性别
- Male
入选标准
- •Age over 40
- •Prostate volume less than 30ml
- •Postvoid residual less than 100ml
- •Patients who agree with the research
排除标准
- •Postvoid residual over 100ml
- •suspected of prostate cancer
- •any medicationfor LUTS within 8 weeks
- •patients with neurogenic disease
- •patients with active urinary infection
- •patients with hypotension
- •patients with severe heart disease
- •patients with severe liver disease
- •pateints with severe kidney disease
- •patients with allergy with tamsulocin/vibegron
研究者
相似试验
已完成
不适用
Effect of tamsulosin and minirin in treatment of BPHBenign Prostatic Hyperplasia.Hyperplasia of prostateIRCT201205219819N1rologyResearch Center354
招募中
4 期
Comparative efficacy assessment of Tamsulosin vs. Tamsulosin plus Pentoxifylline in the treatment of LUTS/BPH: A preliminary studyIRCT20210729052012N1Shiraz University of Medical Sciences60
已完成
不适用
Role of alpha blocker and steroid in better and early clearance of kidney and ureteric stones after extracorporeal lithotripsyCTRI/2018/04/013187SIR GANGA RAM HOSPITA143
尚未招募
4 期
Comparison of tamsulosin vs. tamsulosin plus mirabegron in the management of overactive bladder in men with lower urinary tract symptomsCTRI/2022/09/045280Dr Harmandeep Singh Chahal
尚未招募
4 期
TAMSULOSIN VERSUS ALFUZOSIN IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMSCTRI/2020/06/025806ARMED FORCES MEDICAL COLLEGE